These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36815949)

  • 1. Downregulation of miR-137 Facilitates CD4+ T Cell Pyroptosis in Systemic Lupus Erythematosus via Stimulating AMPK Pathway.
    Gong A; Mi L; Wei F; Zhuang Y; Song Y; Pan C; Zhang X; Lin G; Wu Z; Liu Y
    J Immunol Res; 2023; 2023():1241774. PubMed ID: 36815949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of MiR-98 and Its Underlying Mechanisms in Systemic Lupus Erythematosus.
    Xie L; Xu J
    J Rheumatol; 2018 Oct; 45(10):1397-1405. PubMed ID: 29907673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of miR-633 activated AKT/mTOR pathway by targeting AKT1 in lupus CD4
    Chen S; Wang Y; Qin H; Lin J; Xie L; Chen S; Liang J; Xu J
    Lupus; 2019 Apr; 28(4):510-519. PubMed ID: 30760089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus.
    Ding S; Liang Y; Zhao M; Liang G; Long H; Zhao S; Wang Y; Yin H; Zhang P; Zhang Q; Lu Q
    Arthritis Rheum; 2012 Sep; 64(9):2953-63. PubMed ID: 22549634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsa_circ_0012919 promotes pyroptosis in CD4+T cells of systemic lupus erythematous by miR-125a-3p/GSDMD axis.
    Zhang C; Zhang C; Huang C; Ji J; Liu J; Lu Y
    Exp Dermatol; 2023 Jan; 32(1):41-49. PubMed ID: 36164970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDAC1 potentiates CD4 + T cell activation by inhibiting miR-124 and promoting IRF1 in systemic lupus erythematosus.
    Chen J; Peng L; Zhao Z; Yang Q; Yin F; Liu M; Luo X; He C; He Y
    Cell Immunol; 2021 Apr; 362():104284. PubMed ID: 33550188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of microRNA-101-3p participates in systemic lupus erythematosus progression via negatively regulating HDAC9.
    Sun H; Guo F; Xu L
    J Cell Biochem; 2020 Oct; 121(10):4310-4320. PubMed ID: 31904179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolic acid upregulates miR-142-3P/5P and miR-146a in lupus CD4+T cells.
    Tang Q; Yang Y; Zhao M; Liang G; Wu H; Liu Q; Xie Y; Li D; Dai Y; Yung S; Chan TM; Lu Q
    Lupus; 2015 Aug; 24(9):935-42. PubMed ID: 25661834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of 1,25(OH)2D3 and Vitamin D Receptor in the Pathogenesis of Rheumatoid Arthritis and Systemic Lupus Erythematosus by Regulating the Activation of CD4+ T Cells and the PKCδ/ERK Signaling Pathway.
    He XJ; Ding Y; Xiang W; Dang XQ
    Cell Physiol Biochem; 2016; 40(3-4):743-756. PubMed ID: 27915349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased microRNA(miR)-145 and increased miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis.
    Lu MC; Lai NS; Chen HC; Yu HC; Huang KY; Tung CH; Huang HB; Yu CL
    Clin Exp Immunol; 2013 Jan; 171(1):91-9. PubMed ID: 23199328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The down-regulation of hsa_circ_0012919, the sponge for
    Zhang C; Wang X; Chen Y; Wu Z; Zhang C; Shi W
    Clin Sci (Lond); 2018 Nov; 132(21):2285-2298. PubMed ID: 30237316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression.
    Stagakis E; Bertsias G; Verginis P; Nakou M; Hatziapostolou M; Kritikos H; Iliopoulos D; Boumpas DT
    Ann Rheum Dis; 2011 Aug; 70(8):1496-506. PubMed ID: 21602271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-29b contributes to DNA hypomethylation of CD4+ T cells in systemic lupus erythematosus by indirectly targeting DNA methyltransferase 1.
    Qin H; Zhu X; Liang J; Wu J; Yang Y; Wang S; Shi W; Xu J
    J Dermatol Sci; 2013 Jan; 69(1):61-7. PubMed ID: 23142053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged expression of CD154 on CD4 T cells from pediatric lupus patients correlates with increased CD154 transcription, increased nuclear factor of activated T cell activity, and glomerulonephritis.
    Mehta J; Genin A; Brunner M; Scalzi LV; Mishra N; Beukelman T; Cron RQ
    Arthritis Rheum; 2010 Aug; 62(8):2499-509. PubMed ID: 20506525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF-1α and miR-210 differential and lineage-specific expression in systemic lupus erythematosus.
    Garchow B; Maque Acosta Y; Kiriakidou M
    Mol Immunol; 2021 May; 133():128-134. PubMed ID: 33657462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircIBTK inhibits DNA demethylation and activation of AKT signaling pathway via miR-29b in peripheral blood mononuclear cells in systemic lupus erythematosus.
    Wang X; Zhang C; Wu Z; Chen Y; Shi W
    Arthritis Res Ther; 2018 Jun; 20(1):118. PubMed ID: 29884225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsa_circ_0012919 regulates expression of MDA5 by miR-125a-3p in CD4+ T cells of systemic lupus erythematous.
    Zhang C; Zhang C; Ji J; Xiong X; Lu Y
    Lupus; 2020 Jun; 29(7):727-734. PubMed ID: 32321346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of microRNA-199a-3p expression in CD4
    Wang H; Geng G; Zhang D; Han F; Ye S
    Clin Rheumatol; 2023 Jun; 42(6):1683-1694. PubMed ID: 36763225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TGF-β/miR-31/CEACAM1-S axis inhibits CD4
    Liu Y; Li C; Yang Y; Li T; Xu Y; Zhang W; Li M; Xiao Y; Hu J; Liu K; Li Q; Gui M; Zuo X; Li Y; Zhang H
    Immunol Cell Biol; 2021 Aug; 99(7):697-710. PubMed ID: 33655578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of circular RNA ETS1 promotes SLE activity and inhibits Treg cell differentiation through miR-1205/FoxP3 molecular axis.
    Zou H; Ma S; Li L; Xia X; Zhou Y; Zhang R
    Int Immunopharmacol; 2024 Feb; 128():111539. PubMed ID: 38244519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.